Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nimotuzumab”

146 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 146 results

Large-scale testing (Phase 3)Looking for participantsNCT05978050
What this trial is testing

Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcinoma

Who this might be right for
Gastric or Esophagogastric Junction Adenocarcinoma
Biotech Pharmaceutical Co., Ltd. 354
Early research (Phase 1)Study completedNCT00950417
What this trial is testing

Nimotuzumab in Combination With Chemoradiation for Esophageal Cancer

Who this might be right for
Advanced Esophageal
Biotech Pharmaceutical Co., Ltd. 11
Testing effectiveness (Phase 2)Looking for participantsNCT06509009
What this trial is testing

Nimotuzumab Combined With TGP as First-line Therapy in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma by AJCC V8 Stage
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Testing effectiveness (Phase 2)Ended earlyNCT01382745
What this trial is testing

Nimotuzumab With Radiotherapy in the Treatment of Anal Canal Cancers

Who this might be right for
Squamous Cell Carcinoma of Anal Canal
Dr. Te Vuong 1
Testing effectiveness (Phase 2)UnknownNCT04664244
What this trial is testing

Combination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous Carcinoma

Who this might be right for
Recurrent Cervical CarcinomaRadiotherapyEpidermal Growth Factor Receptor+4 more
Lei Li 43
Large-scale testing (Phase 3)UnknownNCT01074021
What this trial is testing

Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Cancer
Biotech Pharmaceutical Co., Ltd. 480
Testing effectiveness (Phase 2)UnknownNCT01861223
What this trial is testing

Afatinib Plus Nimotuzumb for NSCLC

Who this might be right for
NSCLC
Samsung Medical Center 50
Testing effectiveness (Phase 2)UnknownNCT01180166
What this trial is testing

Combination of Nimotuzumab,Capecitabine and Radiotherapy for Inoperable or Recurrent Gastric Cancer

Who this might be right for
Gastric CancerConcurrent Chemoradiotherapy
Chinese Academy of Medical Sciences 30
Large-scale testing (Phase 3)UnknownNCT04532229
What this trial is testing

Nimotuzumab in Combined With Chemoradiotherapy to Treat the Newly Diagnosed Diffuse Intrinsic Pontine Glioma in Children

Who this might be right for
Diffuse Intrinsic Pontine Glioma
Biotech Pharmaceutical Co., Ltd. 48
Testing effectiveness (Phase 2)UnknownNCT01393184
What this trial is testing

Safety and Efficacy Study of Target Therapy Combined With Radiotherapy to Treat Senile Locally Advanced SCCHN

Who this might be right for
SCCHN
Peking University 92
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06039891
What this trial is testing

Nimotuzumab Plus Tislelizumab for Recurrent and Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Peking Union Medical College Hospital 55
Large-scale testing (Phase 3)Active Not RecruitingNCT04456322
What this trial is testing

Radiotherapy Plus Nimotuzumab or Cisplatin in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 381
Testing effectiveness (Phase 2)Study completedNCT04475016
What this trial is testing

TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in Locally Advanced Penile Cancer

Who this might be right for
Penile Cancer
Sun Yat-sen University 29
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07277452
What this trial is testing

Nimotuzumab Combined With Nab-paclitaxel/Gemcitabine in the Perioperative Treatment of High-risk Resectable/Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, Adult
The First Affiliated Hospital with Nanjing Medical University 156
Large-scale testing (Phase 3)Not Yet RecruitingNCT06343116
What this trial is testing

Nimotuzumab Combined With Trifluridine/Tipiracil in the Treatment of Refractory Metastatic Colorectal Cancer

Who this might be right for
Refractory Metastatic Colorectal Cancer
Biotech Pharmaceutical Co., Ltd. 420
Large-scale testing (Phase 3)Looking for participantsNCT05772208
What this trial is testing

Intensified Treatments for Patients With Locally Advanced Nasopharyngeal Carcinoma With Detectable EBV DNA After One Cycle GP Regime Neoadjuvant Chemotherapy

Who this might be right for
Nasopharyngeal Carcinoma
Fudan University 459
Post-approval studies (Phase 4)UnknownNCT02945267
What this trial is testing

Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic Cancer

Who this might be right for
Unresectable Pancreatic Cancer
Chinese PLA General Hospital 60
Testing effectiveness (Phase 2)WithdrawnNCT01301612
What this trial is testing

Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS)

Who this might be right for
CarcinomaAdenocarcinomaUterine Cervix Adenosquamous Carcinoma
Eurofarma Laboratorios S.A.
Testing effectiveness (Phase 2)UnknownNCT03400592
What this trial is testing

Study of Nimotuzumab and Irinotecan as Second Line With Recurrent or Metastatic Gastric Adenocarcinoma

Who this might be right for
Stomach Neoplasms
Peking University 55
Testing effectiveness (Phase 2)Looking for participantsNCT07353723
What this trial is testing

Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer

Who this might be right for
Head & Neck Cancer
Tang-Du Hospital 10
Load More Results